Nuclear envelope-related lipodystrophies

Area of Science:

• Cell Biology
• Genetics
• Metabolic Disorders

Background:

• Lipodystrophic syndromes are rare genetic or acquired diseases characterized by fat atrophy and metabolic complications like insulin resistance and fatty liver disease.
• Alterations in nuclear envelope proteins, particularly lamins, are associated with these syndromes.
• While adipocyte dysfunction is implicated, the precise link between nuclear envelope defects and lipodystrophy remains unclear.

Purpose of the Study:

• To review the clinical, tissular, and cellular characteristics of lipodystrophies linked to nuclear envelope abnormalities.
• To explore the hypothetical pathophysiological mechanisms connecting nuclear envelope defects to lipodystrophy.

Main Methods:

• Literature review focusing on nuclear envelope proteins (lamins A/C, prelamin-A, lamin B) and their mutations.
• Analysis of clinical phenotypes, including familial partial lipodystrophy (FPLD2).
• Examination of cellular and tissular alterations in affected individuals.

Main Results:

• Specific mutations in lamins A/C (e.g., R482Q) cause familial partial lipodystrophy type 2 (FPLD2).
• Nuclear envelope abnormalities can lead to a spectrum of phenotypes, from partial lipodystrophy to complex syndromes with metabolic, muscular, cardiac, and aging-related issues.
• The review consolidates current knowledge on the clinical presentation and potential mechanisms.

Conclusions:

• Nuclear envelope protein alterations are a significant factor in the pathogenesis of certain lipodystrophic syndromes.
• Understanding these links is crucial for diagnosing and potentially treating these complex metabolic disorders.
• Further research is needed to elucidate the exact molecular pathways involved.